Proteome Systems Limited: The First Five Years Harvard Case Solution & Analysis

Sydney biotech company moves from the development of proteomics technologies to commercialization of its first instruments in the world market proteomics. The case study highlights a number of activities involving the 120-person company, the internal problems of Proteome systems cost as it moves towards commercialization of its technology, and how it solves these problems. In the long term, Proteome Systems wants to be a drug discovery company, and now, at the end of 2003, the Director General is considering buying U.S. drug discovery company Proteome Systems to improve their own products-discovery efforts. "Hide
by Jonathan West, Mona Ashiya Source: Harvard Business School 30 pages. Publication Date: November 24, 2003. Prod. #: 604049-PDF-ENG

Proteome Systems Limited: The First Five Years Case Solution Other Similar Case Solutions like

Proteome Systems Limited: The First Five Years

Share This